Patent Yard Sign in
Expired European patentEurope

Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer

EP 1049465 B1 · Applicant: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed January 22, 1999 and granted October 11, 2006. A European patent lasts at most 20 years from filing, so its term ended January 22, 2019.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by July 22, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledJanuary 22, 1999
PublishedNovember 8, 2000
GrantedOctober 11, 2006
Term endedJanuary 22, 2019
Application numberEP 99903669
Classification (CPC)A61P43/00 +2 more

Timeline

Timeline From EPO dates

2000200220042006200820102012201420162018Application filedJan 22, 1999PublishedNov 8, 2000Patent grantedOct 11, 2006Term endedJan 22, 2019

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.